Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Alaunos Therapeutics Inc TCRT

Healthcare Biotechnology
Alaunos Therapeutics, Inc. is a clinical-stage oncology-focused cell therapy company. The Company is focused on exploring strategic alternatives, including, but not limited to, an acquisition, merger, reverse merger, sale of assets, strategic partnerships, capital raises or other transactions. Separately, the Company is evaluating several potential in-licensing opportunities in obesity... see more

Recent & Breaking News (NDAQ:TCRT)

Mesoblast, Intrexon and ZIOPHARM to Target Cancers

Globe Newswire October 23, 2013

ZIOPHARM Oncology Announces Proposed Public Offering of Common Stock

Globe Newswire October 22, 2013

ZIOPHARM Announces Third Quarter Financial Results and Updates Key Development Activities

Globe Newswire October 22, 2013

ZIOPHARM and Intrexon Announce Presentation of Data Highlighting Regulated Gene Expression System in Tumor-Homing Mesenchymal Stem Cells

Globe Newswire October 22, 2013

Five Star Equities Issues New Research Reports on AMRN, ARIA, ASTM and ZIOP

Accesswire October 22, 2013

ZIOPHARM and Intrexon Announce Presentation of Data Highlighting Versatility of Novel Gene Expression and Control Technology

Globe Newswire October 21, 2013

ZIOPHARM and Intrexon Announce Presentations at the 2013 AACR-NCI-EORTC International Conference

Globe Newswire October 17, 2013

ZIOPHARM Oncology to Present at the 12th Annual BIO Investor Forum

Globe Newswire October 2, 2013

Five Star Equities Issues New Research Reports on GALE, OMER, REGN and ZIOP

Accesswire October 1, 2013

InvestorsGuru.com 41 Filtered Mid-Day Market Movers Recap

Investors Guru September 28, 2013

ZIOPHARM Oncology to Present at BioCentury's 2013 NewsMakers in the Biotech Industry Conference

Globe Newswire September 20, 2013

ZIOPHARM Announces Second Quarter Financial Results and Updates Key Development Activities

Globe Newswire August 8, 2013

Technical Scrutiny: Isis Pharma, Community Health Systems, ZIOPHARM Oncology, and Alere

PR Newswire July 2, 2013

ZIOPHARM Oncology to Present at the 8th Annual JMP Securities Healthcare Conference

Globe Newswire July 2, 2013

ZIOPHARM Announces Presentation of Updated Results From Ad-RTS-IL-12 Phase I Study in Advanced Melanoma at the 2013 ASCO Annual Meeting

Globe Newswire June 1, 2013

ZIOPHARM Oncology to Present at the Jefferies 2013 Global Healthcare Conference

Globe Newswire May 30, 2013

ZIOP, MNKD, ARIA, GALE, and NVAX Early Briefing and Review

Accesswire May 29, 2013

BBRY, FB, DF and ZIOP added to Active Stock Watch List at EPR

Accesswire May 28, 2013

Free Research Reports on FCEL, TNP, VNDA and ZIOP Issued by the Paragon Report

Marketwired May 28, 2013

ZIOPHARM Oncology Inc. is Featured as the Daily Momentum Gainer to Watch on Smallcappower.com

Newsfile May 27, 2013